SAN FRANCISCO, July 25 10, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on advancing cardiac care, today announced the appointment of two seasoned executives to of its management team. Brice Bobzien will join the company as Chief Financial Officer on August 8, 2022, to lead all financial operations for the company as well as to advance the culture of operational excellence and prepare the company for future growth. Reyna Fernandez will join the company as Executive Vice President and Chief Human Resources Officer on July 25, 2022, to lead the development and implementation of human resources strategies in support of the company’s global expansion plans. company.
“We are very pleased to welcome Brice and Reyna to our expanded leadership team as we continue to execute on our vision to make iRhythm a market leader in digital healthcare,” said Quentin Blackford. , President and CEO of iRhythm. “Brice is a seasoned executive who brings extensive experience in building finance teams and guiding organizations through operational transformations. His focus on operational excellence with a disciplined and disciplined approach to financial management and strategic development will position us well for the future. With the addition of Brice as CFO, this will allow Doug to focus on the continuous improvement of our operational functions which he will continue to lead. Reyna is a seasoned HR executive with over 25 years of experience building HR teams, implementing talent development programs and transforming organizations to operate strategically, holistically and effectively. We look forward to these two accomplished individuals joining our team to help lead the organization through significant growth with a focus on operational effectiveness and efficiency.
About Mr. Bobzien
Brice Bobzien most recently served as Senior Vice President, Finance and Investor Relations at Dexcom, Inc., where he was responsible for global financial planning and analysis, investor relations, operations and global pricing strategy. Brice has been instrumental in driving revenue growth initiatives that have seen the company grow from $700 million to projected revenue of approximately $2.9 billion in fiscal 2022. This growth included scaling the company’s global footprint, expanding beyond the United States and into more than 50 countries. During this time, Brice transformed the finance team into a world-class organization designed to drive revenue growth and operational discipline. Brice’s background includes over 20 years of experience and increasing responsibilities at leading medical device companies including Zimmer Holdings, Inc., NuVasive, Inc. and Dexcom, Inc. Prior to these roles, Brice began his career in accounting. Brice received his Bachelor of Science in Business Administration from Indiana University, Fort Wayne, and is a Certified Public Accountant (non-practicing) in the State of Indiana.
About Ms. Fernandez
Reyna Fernandez most recently served as Director of Human Resources at Intersect ENT, Inc., where she was responsible for designing and implementing human resource strategies to help the company become an integrated, world-class player in the therapeutic area. Reyna has been instrumental in the continued growth of Intersect ENT through best-in-class talent acquisition, organizational effectiveness and human capital management functions. During her tenure with the company, she partnered with the CEO and management to create a performance culture focused on growth and operational excellence, transformed the HR organization so that it operates globally in line with business objectives and has worked strategically with the board to align with compensation practices. Reyna brings global experience from her roles at Endologix, Inc., Canon Medical Systems USA, Inc., Johnson & Johnson and Bristol-Myers Squibb Company. Reyna received her Masters in Social Administration from Columbia University and a Bachelor of Arts in Cultural Anthropology from Haverford College in Pennsylvania.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable insights. The company believes that improvements in the detection and characterization of arrhythmias have the potential to change the clinical management of patients.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These statements are based on current assumptions. which involve risks and uncertainties, and actual results and achievements could differ materially from those anticipated. Risks and uncertainties that could cause actual results to differ materially from current expectations, many of which are beyond our control, include risks described in more detail in iRhythm’s Quarterly Report on Form 10-Q for the Period Ended on March 31, 2022, as filed with the Securities and Exchange Commission on May 6, 2022. These forward-looking statements speak only as of the date hereof and should not be relied upon unduly. Except as required by law, iRhythm undertakes no obligation to update these forward-looking statements after the date of this release.
iRhythm Media Contact